Assessment of ICP in Idiopathic Intracranial Hypertension Using Transocular Ultrasound and Transcranial Doppler
Assessment of Raised Intracranial Pressure in Patients With Idiopathic Intracranial Hypertension by Optic Nerve Sheath Diameter and Transcranial Doppler Measurements
1 other identifier
interventional
78
1 country
1
Brief Summary
Idiopathic Intracranial Hypertension (IIH) is a rare disease, primarily affecting overweight females of child-bearing age. Patients suffer from increased intracranial pressure (ICP), typically resulting in headaches, visual disturbances and bilateral papilledema, pulsatile tinnitus and cognitive deficits. The disease is difficult to diagnose, treat and monitor. The only current method of measuring the ICP in day-to-day clinical practice is by lumbar puncture. This procedure is invasive, and often painful for the patient. There is an unmet need of methods that can reliable measure or estimate ICP in a non-invasive manner. Ultrasound is one such potential method, and the aim of this study is to investigate the use of ocular ultrasound and transcranial doppler to measure or estimate ICP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
March 12, 2020
CompletedFirst Posted
Study publicly available on registry
March 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedMarch 7, 2023
March 1, 2023
3.1 years
March 12, 2020
March 6, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Correlation between opening pressure and ONSD
Optic nerve sheath diameter (ONSD) potential correlation with opening pressure.
1 year
Correlaton between opening pressure and ONSD/ETD ratio
ONSD/ETD (external transverse diameter) ratio and potential correlation with opening pressure.
1 year
Comparison of ONSD in IIH and healthy controls
Comparison of ONSD in patients with elevated ICP (IIH) and healthy controls, age- sex and BMI matched.
1 year
Secondary Outcomes (10)
Optic disc elevation
1 year
ONSD diameter on MR c in patients with IIH
1 year
Changes in the optic nerve (ONSD)
1 month
Changes in the optic nerve (ONSD)
6 months
Changes in the optic nerve (ODE)
1 month
- +5 more secondary outcomes
Study Arms (1)
Patients suspected of IIH at baseline
OTHERIntervention: TOS and TCD measurements at baseline, and at routine follow-ups. Healthy controls will be recruited to match the patients.
Interventions
TOS: Transorbital sonography TCD: Transcranial Doppler
Eligibility Criteria
You may qualify if:
- Age 18-65
- Patients in whom the IIH diagnosis is suspected/or confirmed
- The diagnosis of migraine with or without aura or tension-type headache is allowed as a comorbid headache type.
- Participants must read and understand the Danish language, or have an official interpreter present to be able to understand the work-up and sign the participation consent for the study
You may not qualify if:
- Pregnant or breastfeeding females
- Patients who do not need a diagnostic lumbar puncture at the time of evaluation
- Any other primary or secondary headache diagnosis than migraine with or without aura or tension type headache as a comorbid disorder
- Patients in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases
- Participants with secondary causes of raised intracranial pressure, or patients that have been treated for such (e.g. brain tumor, hydrocephalus, stroke or severe head injury)
- Participants with known atherosclerotic disease or known heart disease
- CONTROL GROUP (ARM 2):
- Age 18-65
- Healthy persons who do not suffer from any form of primary headache except infrequent tension-type headache
- Participants must read and understand the Danish language or have an official interpreter present to be able to sign the participation consent for the study.
- Pregnant or breastfeeding females
- Participants in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Danish Headache Center
Glostrup Municipality, Capital Region, 2600, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rigmor Jensen, Dr.med.
Danish Headache Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
March 12, 2020
First Posted
March 19, 2020
Study Start
January 1, 2020
Primary Completion
February 1, 2023
Study Completion
February 1, 2023
Last Updated
March 7, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share